Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis

PURPOSE: The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally advanced disease, the role of adding radiotherapy is not certain. We evaluated the outcomes of patients with high-risk endometrial ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues da Cunha Colombo Bonadio, Renata, Gondim Meira Velame Azevedo, Renata, Harada, Guilherme, Cabral Severino da Costa, Samantha, Costa Miranda, Vanessa, de Freitas, Daniela, Abdo Filho, Elias, Alves de Oliveira Ferreira, Patricia, Gabrielli, Flavia, Del Pilar Estevez Diz, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223436/
https://www.ncbi.nlm.nih.gov/pubmed/30241227
http://dx.doi.org/10.1200/JGO.17.00146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223436/
https://www.ncbi.nlm.nih.gov/pubmed/30241227
http://dx.doi.org/10.1200/JGO.17.00146

Ejemplares similares